IGFBP2 promotes glioma tumor stem cell expansion and survival

Biochemical and Biophysical Research Communications

Volumn 397, Issue 2, 2010, Pages 367-372

  Hsieh, David ^a   Hsieh, Antony ^b   Stea, Baldassarre ^a   Ellsworth, Ron ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glioblastoma; IGF; IGFBP2; Tumor stem cell

Indexed keywords

CYCLIN DEPENDENT KINASE 4; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 2; PROTEIN KINASE B;

ARTICLE; CANCER STEM CELL; CELL CULTURE; CELL EXPANSION; CELL SURVIVAL; DRUG RESISTANCE; GENOTOXICITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ANALYSIS; BRAIN TUMOR; CELL CLONE; CELL CYCLE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CLONE CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION, GENETIC;

EID: 77955475753     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.05.145     Document Type: Article

References (25)

1. A.A. Samani, S. Yakar, D. LeRoith, P. Brodt, The role of the IGF system in cancer growth and metastasis: overview and recent insights, Endocr. Rev. 28 (2007) 20-47.
2. V. Hwa, Y. Oh, R.G. Rosenfeld, The insulin-like growth factor-binding protein (IGFBP) superfamily, Endocr. Rev. 20 (1999) 761-787.
3. X. Zhang, D. Yee, Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility, Cancer Res. 62 (2002) 4369-4375.
4. J.V. Silha, P.C. Sheppard, S. Mishra, Y. Gui, J. Schwartz, J.G. Dodd, L.J. Murphy, Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms, Endocrinology 147 (2006) 2112-2121.
5. S.L. Leng, K.S. Leeding, R.H. Whitehead, L.A. Bach, Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells, Mol. Cell. Endocrinol. 174 (2001) 121-127.
6. M.W. Elmlinger, M.H. Deininger, B.S. Schuett, R. Meyermann, F. Duffner, E.H. Grote, M.B. Ranke, In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade, Endocrinology 142 (2001) 1652-1658.
7. Y. Lin, T. Jiang, K. Zhou, L. Xu, B. Chen, G. Li, X. Qiu, W. Zhang, S.W. Song, Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas, Neurol. Oncol. 11 (2009) 468-476.
8. S.M. Dunlap, J. Celestino, H. Wang, R. Jiang, E.C. Holland, G.N. Fuller, W. Zhang, Insulin-like growth factor binding protein 2 promotes glioma development and progression, Proc. Natl. Acad. Sci. USA 104 (2007) 11736-11741.
9. S. Chakrabarty, L. Kondratick, Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells, Cancer Biol. Ther. 5 (2006) 189-197.
10. G.K. Wang, L. Hu, G.N. Fuller, W. Zhang, An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility, J. Biol. Chem. 281 (2006) 14085-14091.
11. H. Wang, W. Shen, H. Huang, L. Hu, L. Ramdas, Y.H. Zhou, W.S. Liao, G.N. Fuller, W. Zhang, Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes, Cancer Res. 63 (2003) 4315-4321.
12. T. Fukushima, T. Tezuka, T. Shimomura, S. Nakano, H. Kataoka, Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24, J. Biol. Chem. 282 (2007) 18634-18644.
13. L.M. Moore, K.M. Holmes, S.M. Smith, Y. Wu, E. Tchougounova, L. Uhrbom, R. Sawaya, J.M. Bruner, G.N. Fuller, W. Zhang, IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas, Proc. Natl. Acad. Sci. USA 106 (2009) 16675-16679.
14. T. Reya, S.J. Morrison, M.F. Clarke, I.L. Weissman, Stem cells, cancer, and cancer stem cells, Nature 414 (2001) 105-111.
15. S.K. Singh, C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cusimano, P.B. Dirks, Identification of human brain tumour initiating cells, Nature 432 (2004) 396-401.
16. C. Wiese, A. Rolletschek, G. Kania, P. Blyszczuk, K.V. Tarasov, Y. Tarasova, R.P. Wersto, K.R. Boheler, A.M. Wobus, Nestin expression - a property of multi-lineage progenitor cells?, Cell Mol. Life Sci. 61 (2004) 2510-2522.
17. J. Dahlstrand, V.P. Collins, U. Lendahl, Expression of the class VI intermediate filament nestin in human central nervous system tumors, Cancer Res. 52 (1992) 5334-5341.
18. W. Jiang, C. Xiang, S. Cazacu, C. Brodie, T. Mikkelsen, Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration, Neoplasia 10 (2008) 1335-1342.
19. H. Wang, W. Zhang, G.N. Fuller, Overexpression of IGFBP5, but not IGFBP3, correlates with the histologic grade of human diffuse glioma: a tissue microarray and immunohistochemical study, Technol. Cancer Res. Treat. 5 (2006) 195-199.
20. A. Eramo, L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti, G. Sette, E. Pilozzi, L.M. Larocca, C. Peschle, R. De Maria, Chemotherapy resistance of glioblastoma stem cells, Cell Death Differ. 13 (2006) 1238-1241.
21. S. Bao, Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, A.B. Hjelmeland, M.W. Dewhirst, D.D. Bigner, J.N. Rich, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature 444 (2006) 756-760.
22. G.G. Chiang, R.T. Abraham, Targeting the mTOR signaling network in cancer, Trends Mol. Med. 13 (2007) 433-442.
23. D.R. Laks, M. Masterman-Smith, K. Visnyei, B. Angenieux, N.M. Orozco, I. Foran, W.H. Yong, H.V. Vinters, L.M. Liau, J.A. Lazareff, P.S. Mischel, T.F. Cloughesy, S. Horvath, H.I. Kornblum, Neurosphere formation is an independent predictor of clinical outcome in malignant glioma, Stem Cells 27 (2009) 980-987.
24. N. Sanai, A. Alvarez-Buylla, M.S. Berger, Neural stem cells and the origin of gliomas, N. Engl. J. Med. 353 (2005) 811-822.
25. H. Kiaris, A.V. Schally, J.L. Varga, Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice, Neoplasia 2 (2000) 242-250.